[1] 罗永艾.结核病合并人类免疫缺陷病毒感染/艾滋病的诊断[J].中华结核和呼吸杂志(Chin J Tuberc Respir Dis),2000,23(11):656-8. [2] 肖和平,何国钧.结核病合并人类免疫缺陷病毒感染/艾滋病的处理[J].中华呼吸和结核杂志(Chin J TubercRespirDis),2000,23(11):659-61 [3] 赵晓梅,吕维柏.艾滋病并发结核病78例临床研究[J].中国性病艾滋病防治(Zhong Guo Xing Bing Ai Zi Bing Fang Zhi),1996,2(3):130-2. [4] Smith RL,Yew K,Berkowitz CP, et al. Factors affecting the yield of acid-fast sputum smears in patients with HIV and tuberculosis [J].Chest, 1994, 106(3):684-6. [5] 张敦熔.现代结核病学[M].北京:人民卫生出版社,2000.565. [6] Ackan AN, Coulibaly D, Digbeu H, et al. Response to treatment,mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cte d’lvoire [J]. Lancet, 1995, 345(8949):607-60. [7] 谢惠安,阳国太,林善梓.现代结核病学[M].北京:人民卫生出版社.2000.443. [8] Girardi E, Palmieri F, Cingolani A, et al. Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy[J]. J Acquir Immune Defic Syndr, 2001, 26(4):326-31. [9] 康来仪,潘孝彰.获得性免疫缺陷综和征抗逆转录病毒治疗的发展和应用[J].中华传染病杂志(Chin J Infect Dis),2002,20(3):133-6. [10] US Dept. of Health and Human Services ·Guideline for the use of antiretroviral agents in HIV-infected adults and adolescents [M].Washirgton DC:US Dept. Of Health and Human Services, 2001. [11] Park MM, Davis AL, Schluger NW, et al. Outcome of MDR-TB Patients, 1983- 1993:prolonged survival with appropriate therapy[J].Am J Respir Crit Care Med, 1996, 153(1):317-24. |